Music therapy and neurological outcomes: what the 2025 research found
A summary of significant peer-reviewed studies published in 2025 examining the measurable effects of active and receptive music therapy on neurological conditions including dementia, depression, stroke rehabilitation and autism.
Music therapy — the clinical use of music interventions by a qualified music therapist to achieve therapeutic goals — has accumulated a substantial evidence base over the past two decades. The year 2025 produced several significant studies examining measurable outcomes across neurological and psychiatric conditions. This article summarises the key findings and what they suggest for the role of music in healthcare.
Dementia and cognitive decline
A multi-site randomised controlled trial published in the Journal of Alzheimer's Disease (2025) examined the effects of active group music therapy (weekly sessions involving singing, rhythm activities and music reminiscence) on 340 participants with mild-to-moderate Alzheimer's disease across five UK and European sites. Participants receiving music therapy showed statistically significant improvements in quality of life measures, reduction in agitation behaviours, and slower decline in verbal fluency over a 12-month period compared to the control group receiving standard care. The study did not demonstrate significant effects on cognitive test scores (MMSE), consistent with prior research suggesting music therapy primarily affects behavioural and quality-of-life outcomes rather than cognitive performance per se. The British Association for Music Therapy notes this study as one of the most methodologically rigorous trials of music therapy in dementia to date.
Stroke rehabilitation
A systematic review and meta-analysis published in Neuropsychological Rehabilitation (2025) pooled data from 22 randomised trials examining music therapy and music-assisted rehabilitation in stroke survivors. The analysis found statistically significant positive effects of rhythm-based interventions (rhythmic auditory stimulation, or RAS) on gait rehabilitation — walking speed, stride length and cadence — with effect sizes considered clinically meaningful. Evidence for music therapy effects on upper limb rehabilitation was more mixed but showed positive trends in fine motor function. The review noted that the mechanisms are relatively well understood: rhythmic auditory stimulation entrains the motor system through the basal ganglia, providing a temporal template for movement that improves coordination and efficiency. RAS is now incorporated into several NHS stroke rehabilitation protocols.
Mental health outcomes
A large cohort study using NHS data (published in BMJ Open, 2025) examined whether participation in community music activities (amateur choirs, community orchestras, music groups) was associated with reduced rates of depression diagnosis or antidepressant prescription in adults aged 40–75. The study found statistically significant associations between regular community music participation and lower rates of depression diagnosis, after controlling for socioeconomic factors, social network size and other confounds. The observational design means causality cannot be established — people with better mental health may be more likely to participate in community music. However, the association was robust across multiple model specifications. The study adds to a growing body of evidence supporting music participation as a component of mental health promotion, even outside formal clinical music therapy.
Frequently asked questions
Music therapy involves a qualified music therapist designing and delivering an intervention tailored to a specific patient's therapeutic goals — it is an active, relationship-based clinical process. Music medicine (or music-based interventions) refers to the use of recorded music as a passive intervention — playing music to patients without a therapist — typically to reduce anxiety before procedures, manage pain or improve mood in hospital settings. Both have evidence bases but they are distinct practices. Music therapists in the UK must be registered with the Health and Care Professions Council (HCPC) and hold a postgraduate qualification in music therapy.
Rhythmic auditory stimulation (RAS) uses a regular rhythmic auditory signal — typically a metronome or music with a strong, consistent beat — to provide an external temporal cue for walking. The auditory system has a strong coupling to the motor system through the basal ganglia and supplementary motor areas; a consistent rhythmic cue helps the motor system maintain regular timing in its movement output. For stroke survivors with disrupted gait timing, this external temporal template can significantly improve walking regularity. The tempo of the cue is typically set slightly faster than the patient's current walking rate to gradually increase gait speed as therapy progresses.
In the UK, music therapy is a regulated health profession. To practise as a music therapist, you must complete an HCPC-approved postgraduate programme (typically an MA in Music Therapy, two years full-time or three years part-time) and register with the HCPC. Entry requirements include a high level of musicianship (usually degree-level or equivalent practical musical skill), relevant experience in a healthcare, educational or social care setting, and personal qualities suited to clinical work. The British Association for Music Therapy (BAMT) maintains a directory of approved training programmes and resources for those considering the profession.